# COVID Vaccine Study OAR Supplement to MWCCS

> **NIH NIH U01** · EMORY UNIVERSITY · 2021 · $34,352

## Abstract

Project Summary/Abstract
MWCCS participants are a high-risk group for severe COVID-19 disease in terms of being HIV-infected,
predominately of elderly age, and having numerous underlying comorbidities. Therefore, it is imperative for their
health that they be vaccinated with the new COVID-19 vaccines. To date, however, there are only anecdotal
data on COVID-19 vaccine acceptance and efficacy in people with HIV (PWH). The MWCCS is ideal for
analyzing (a) the acceptancy and effects of COVID-19 vaccine(s) in male and female PWH and matched HIV-
uninfected controls (HUC), (b) the impact of age and co-morbidities on vaccine immune response and protection
against COVID-19, and (c) the social, economic, and behavioral changes after COVID-19 immunization as
compared to the individuals who opted to not take the vaccine. To address this issue, we will have 2 groups of
MWCCS participants in this study: Group A: Male and female PWH and HUC who choose to receive a COVID-
19 vaccine, Group B: Male and female PWH and HUC who choose NOT to receive a COVID-19 vaccine.

## Key facts

- **NIH application ID:** 10389426
- **Project number:** 3U01HL146241-03S1
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Ighovwerha Ofotokun
- **Activity code:** U01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $34,352
- **Award type:** 3
- **Project period:** 2019-04-01 → 2026-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10389426

## Citation

> US National Institutes of Health, RePORTER application 10389426, COVID Vaccine Study OAR Supplement to MWCCS (3U01HL146241-03S1). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/10389426. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*